000 | 01965 a2200589 4500 | ||
---|---|---|---|
005 | 20250516141629.0 | ||
264 | 0 | _c20140723 | |
008 | 201407s 0 0 eng d | ||
022 | _a1097-0347 | ||
024 | 7 |
_a10.1002/hed.23235 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLee, Jang-Jaer | |
245 | 0 | 0 |
_aFactors predicting the prognosis of oral alendronate-related osteonecrosis of the jaws: a 4-year cohort study. _h[electronic resource] |
260 |
_bHead & neck _cDec 2013 |
||
300 |
_a1787-95 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAlendronate _xadverse effects |
650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
650 | 0 | 4 |
_aAmoxicillin _xtherapeutic use |
650 | 0 | 4 |
_aAmoxicillin-Potassium Clavulanate Combination _xtherapeutic use |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xpathology |
650 | 0 | 4 |
_aBone Density Conservation Agents _xadverse effects |
650 | 0 | 4 | _aBone Remodeling |
650 | 0 | 4 |
_aChlorhexidine _xtherapeutic use |
650 | 0 | 4 |
_aClindamycin _xtherapeutic use |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aCollagen Type I _xblood |
650 | 0 | 4 | _aDebridement |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMouthwashes _xtherapeutic use |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
650 | 0 | 4 |
_aPeptides _xblood |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRetrospective Studies |
700 | 1 | _aCheng, Shih-Jung | |
700 | 1 | _aWang, Jai-Jen | |
700 | 1 | _aChiang, Chun-Pin | |
700 | 1 | _aChang, Hao-Hueng | |
700 | 1 | _aChen, Hsin-Ming | |
700 | 1 | _aKok, Sang-Heng | |
773 | 0 |
_tHead & neck _gvol. 35 _gno. 12 _gp. 1787-95 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hed.23235 _zAvailable from publisher's website |
999 |
_c22595331 _d22595331 |